Top Stories
The series B financing supports the Chinese company's oral GLP-1 candidate and expansion of its AI drug-discovery engine.
Novartis adds 322 jobs to NJ layoff tallyMeiraGTx gets $400M infusion for gene therapy trioFore fields a further $67.4M in series D funding Boehringer inks cancer vaccine licensing deal Novartis adds ...
The deal follows a June scale-up for GenoSphere, which Helix said has doubled in size each of the past two years and is tracking towards one million linked clinico-genomic records within 18 months.
A rolling FDA submission for COMP360, a synthetic formulation of psilocybin, to treat treatment-resistant depression is underway.
The weekly injectable therapy significantly reduced proteinuria in Phase III, but long-term kidney protection remains under study.
Conference News
ROCHESTER, N.Y., July 08, 2026 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) through the inhibiti...
Long-term rozanolixizumab treatment cycles showed repeated and consistent benefit across ocular and wider generalized myasthenia gravis (gMG) symptoms: Final pooled data from the Phase 3 MycarinG stud...
NEWTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyl...
We are excited to participate in AHRA 2026 and engage with imaging leaders from across the healthcare industry”— Dr Ashish Dhawad, Founder & CEO, MedsynapticORLANDO, FL, UNITED STATES, July 7, 2026 /E...
Lausanne, Switzerland, July 7, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announces three p...
